Articles

• Open Access

  Harmful neutrophil subsets in patients with ischemic strokeAssociation with disease severity

  David Weisenburger-Lile, Yuan Dong, Marion Yger, Gaëlle Weisenburger, Giulia Frasca Polara, Thomas Chaigneau, Riccardo Zapata Ochoa, Beatrice Marro, Bertrand Lapergue, Sonia Alamowitch, Carole Elbim

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  α4-integrin deficiency in B cells does not affect disease in a T-cell–mediated EAE disease model

  Rehana Z. Hussain, Petra D. Cravens, William A. Miller-Little, Richard Doelger, Valerie Granados, Emily Herndon, Darin T. Okuda, Todd N. Eagar, Olaf Stüve

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Pilot study of a ketogenic diet in relapsing-remitting MS

  J. Nicholas Brenton, Brenda Banwell, A.G. Christina Bergqvist, Diana Lehner-Gulotta, Lauren Gampper, Emily Leytham, Rachael Coleman, Myla D. Goldman

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Different MRI patterns in MS worsening after stopping fingolimod

  Caterina Lapucci, Damiano Baroncini, Maria Cellerino, Giacomo Boffa, Ilaria Callegari, Matteo Pardini, Giovanni Novi, Maria Pia Sormani, Giovanni Luigi Mancardi, Angelo Ghezzi, Mauro Zaffaroni, Antonio Uccelli, Matilde Inglese, Luca Roccatagliata

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?

  Hadas Stiebel-Kalish, Mark Andrew Hellmann, Michael Mimouni, Friedemann Paul, Omer Bialer, Michael Bach, Itay Lotan

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  CSF parameters associated with early MRI activity in patients with MS

  Ana Klein, Rebecca C. Selter, Alexander Hapfelmeier, Achim Berthele, Bertram Müller-Myhsok, Viola Pongratz, Christiane Gasperi, Claus Zimmer, Mark Mühlau, Bernhard Hemmer

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Natalizumab treatment reduces microglial activation in the white matter of the MS brain

  Marcus Sucksdorff, Jouni Tuisku, Markus Matilainen, Anna Vuorimaa, Sarah Smith, Joonas Keitilä, Johanna Rokka, Riitta Parkkola, Marjo Nylund, Juha Rinne, Eero Rissanen, Laura Airas

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Guillain-Barré syndrome and related diseases after influenza virus infection

  Masaki Yamana, Motoi Kuwahara, Yuta Fukumoto, Keisuke Yoshikawa, Kazuo Takada, Susumu Kusunoki

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Age mattersImpact of data-driven CSF protein upper reference limits in Guillain-Barré syndrome

  Pierre R. Bourque, John Brooks, Christopher R. McCudden, Jodi Warman-Chardon, Ari Breiner

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Neuromyelitis optica spectrum disorderPatient experience and quality of life

  Janine Beekman, Aysha Keisler, Omar Pedraza, Masayuki Haramura, Athos Gianella-Borradori, Eliezer Katz, John N. Ratchford, Gerard Barron, Lawrence J. Cook, Jacinta M. Behne, Terrence F. Blaschke, Terry J. Smith, Michael R. Yeaman

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis

  Michalis L. Kosmidis, Dimitris Pikazis, Panayotis Vlachoyiannopoulos, Athanasios G. Tzioufas, Marinos C. Dalakas

  • Abstract
  • Full Text
  • Full Text (PDF)